The press releases
CHO Morcenx power plant: update on the acceptance of the second GE Jenbacher engine
Tuesday, 21 March 2017 00:00

The acceptance of the first GE Jenbacher on 20 February has caused a time lag. [Read the press release] in French

Number of shares and voting rights as at 28/02/2017
Wednesday, 08 March 2017 00:00

Europlasma declares the number of voting rights and shares comprising its share capital as at 28 February 2017. [Read the press release] in French

CHO Morcenx power plant: acceptance of the first Jenbacher's engine
Monday, 20 February 2017 00:00

The CHO Morcenx gasification plant resumed operations on 21 January 2017, after executing some minor optimisation works, and the acceptance test protocol of the first Jenbacher engine was successfully completed on 18 February. [Read the press release]

Issuance of OCABSA / CHO Morcenx power plant
Monday, 23 January 2017 00:00

Europlasma announces:

  • the request of the issuance of OCABSA tranche 9 for an amount of € 1,000,000 million
  • the postponment, by the engines manufacturer, of the arrival of qualified technicians to carry out the first engine commissioning tests at CHO Morcenx power plant

[Read the press release] in French

Half-year report on liquidity contract
Friday, 06 January 2017 00:00

Under the liquidity contract entrusted by Kepler Cheuvreux, the following assests appeared on the liquidity account at 31 December 2016 [Read the press release]

Corporate events
Thursday, 22 December 2016 00:00

Europlasma announces:

  • The appointment of Stéphan KRYMER as Chief Financial Officer
  • The issuance of the eighth tranche of OCABSA reserved for Bracknor Fund
  • The crossing of thresholds by Crédit Suisse Asset Management (CSAM) [Read the press release] in French
Update on the different business units
Monday, 19 December 2016 00:00

Europlasma announces the slight delay of the Final Acceptance (FA) of the CHO Morcenx power plant, the recovery of the nominal production of Inertam asbestos treatment plant and the finalization of the plasma units in Bulgaria and in China, before their upcoming commissioning. [Read the press release] (in French)

Issuance of OCABSA Tranch 7
Thursday, 15 December 2016 00:00

Europlasma announces the issuance of a 7th tranche of OCABSA for an amount of €1,000,000. [Read the press release] in French

Nuclear Industry calls on Europlasma once again
Monday, 07 November 2016 00:00

Europlasma announces today booking an order for the engineering and supply of a plasma heating system for the treatment of intermediate-level radioactive waste on behalf of a world leader in the nuclear industry. [Read the press release]

Half-yearly results at 30 June 2016
Wednesday, 26 October 2016 00:00

Europlasma today announced its results for the half-year ended 30 June 2016, after limited review by the Statutory Auditors and closed by the Board of Directors on 26 October 2016. [Read the press release]

Follow-up on Group activity
Wednesday, 31 August 2016 00:00

Europlasma announces:

  • The delivery of the additional engines at CHO Morcenx plant on 6 September 2016
  • The resumption of production at Inertam
  • The return of Erik Martel within the Board of Directors

[Read the press release] in French

Europlasma announces changes in its governance and financing structure
Thursday, 21 July 2016 00:00

Resignation of Crédit Suisse Asset Management (CSAM) and implementation of a flexible bond financing through the issuance of OCA (notes convertible into shares) and OCABSA (shares and warrants giving access to notes convertible into shares with share subscription warrants attached) for a maximum amount of €15 million bond issue. [Read the press release] in French

Activity review
Thursday, 21 July 2016 00:00
  • CHO Power: encouraging results of endurance tests in Morcenx
  • Inertam: temporary shutdown of the vitrification unit
  • Europlasma Industries: end assembly of the plasma unit for KNPP in Bulgaria
    [Read the press release] in French
The CHO TIPER project is approved by french authorities and receives a 12m€ support from ADEME
Wednesday, 13 July 2016 00:00

The CHO TIPER renewable energy plant is approved by French authorities, and is financially supported by Ademe as part of the “Investissements d’Avenir” programme

[Read the press release]

Half-Year report as at 30 June 2016 on the liquidity contract
Tuesday, 05 July 2016 00:00

Under the liquidity contract entrusted by Kepler Cheuvreux, the following assests appeared on the liquidity account at 30 June 2016:

  • €18,129.41 (cash)

[Read the press release]

Renouvellement éligibilité dispositif PEA-PME
Thursday, 30 June 2016 00:00

Europlasma confirme le renouvellement de son éligibilité au dispositif PEA-PME [Lire le communiqué]

Filing of the 2015 Registration Document
Thursday, 28 April 2016 00:00

Europlasma announces that its 2015 Registration Document has been filed with the French "Autorité des Marchés Financiers" (AMF). [Read the press release]

2015 annual results and highlights
Thursday, 21 April 2016 00:00

Europlasma announces its results for the year ended 31 December 2015.

At consolidated level:
  • First results from the strategic shift: a significant improvement in sales and operating performance in each of the Group's three divisions.
    • Revenues of €14.1 million, up 57% on 2014, driven by growth in each of the sectors.
    • Net loss of €16.2 million, reduced by 38%.

At divisional level:

  • Positive contribution of Plasma Solutions (excluding Corporate costs) and Asbestos treatment to the Group EBITDA level.
  • Major progress for the Renewable Energies division, which obtained the Final Acceptance with Reserves (FAR), opening the way for the final delivery.
Appointment of a new Director
Wednesday, 20 April 2016 00:00

Europlasma announces the appointment of Yann Le Doré as independent Director. [Read the press release]

2015 Turnover and implementation of equity line financing
Thursday, 25 February 2016 00:00

Europlasma announces its 2015 turnover, outlines its financial position and establishes new equity line financing to fund growth in 2016.

  • 2015 consolidated revenue: up 57% year-on-year to €14.1 million, with robust growth in all three group divisions.
  • Strengthened and diversified sources of financing to meet cash requirements until the end of 2016 with a view to supporting its development.
  • Implementation of equity line financing for a maximum amount of €10 million with Kepler Cheuvreux.
<< Start < Prev 1 2 3 Next > End >>

Page 2 of 3

Stock Exchange Contact

Any financial question

Given the number of calls and regulatory constraints, the company is sorry to inform shareholders that it is no longer able to individually answer incoming calls. Thank you to address any questions via email to

Financial News

26-07-2017: Issuance of the last tranche of OCABSA
[Read more]